Zydus Life Science Stock Screener | Share Price & Fundamental Analysis
ZYDUSLIFE
Pharmaceuticals
Share Price NSE
₹900.75
▼
-1.65 (-0.18%)
Share Price BSE
₹901.00
▼
-1.25 (-0.14%)
Track Zydus Life Science share price live with TickJournal's free stock screener.
Analyze Zydus Life Science share price history trends and compare 52-week high low
levels.
Calculate ZYDUSLIFE stock fair value using fundamental analysis and view live share price charts.
Determine Zydus Life Science share intrinsic value and compare it with current ZYDUSLIFE share price.
Record your Zydus Life Science trades in TickJournal's free trading journal and track your portfolio performance.
Zydus Life Science Market Cap
₹91,612.57 Cr.
EPS (TTM)
₹44.97
Dividend Yield
1.22%
Debt to Equity
0.09
ZYDUSLIFE 52 Week High
₹1049.95
Zydus Life Science 52 Week Low
₹822.10
Operating Margin
24.00%
Profit Margin
14.84%
ZYDUSLIFE Revenue (TTM)
₹6,892.00
EBITDA
₹1,759.00
Net Income
₹1,023.00
Total Assets
₹37,202.00
Total Equity
₹26,358.00
Zydus Life Science Share Price History - Stock Screener Chart
Screen ZYDUSLIFE historical share price movements with interactive charts. Analyze price trends and patterns.
Zydus Life Science Company Profile - Fundamental Screener
Screen Zydus Life Science company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for ZYDUSLIFE shares.
Zydus Lifesciences Limited is an Indian global life sciences company that discovers, develops, manufactures, and markets healthcare therapies. Its product portfolio includes active pharmaceutical ingredients, human formulations, animal health products, and wellness products. The company operates in pharmaceuticals, covering human and veterinary formulations, bulk drugs, diagnostics, herbal products, skin care,...more
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
Chairperson/CEO
Pankaj R Patel
ISIN
INE010B01027
Website
https://www.zyduscadila.com
Zydus Life Science Balance Sheet Screener
Screen ZYDUSLIFE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 37,202 | 29,281 | 25,756 | 27,795 | 23,885 | 23,687 | 23,483 | 0 | 15,221 | 10,551 |
| Current Assets | 17,046 | 11,420 | 10,008 | 12,095 | 8,716 | 8,715 | 8,498 | 0 | 6,022 | 4,280 |
| Fixed Assets | 13,134 | 12,369 | 11,521 | 12,189 | 12,133 | 12,231 | 12,164 | 0 | 5,755 | 3,748 |
| Liabilities | ||||||||||
| Total Liabilities | 37,202 | 29,281 | 25,756 | 27,795 | 23,885 | 23,687 | 23,483 | 0 | 15,221 | 10,551 |
| Current Liabilities | 1,802 | 1,840 | 541 | 915 | 1,094 | 3,707 | 4,461 | 0 | 2,799 | 1,255 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 26,358 | 22,102 | 19,688 | 19,054 | 14,930 | 11,710 | 11,679 | 0 | 7,116 | 5,835 |
| Share Capital | 101 | 101 | 101 | 102 | 102 | 102 | 102 | 0 | 102 | 102 |
| Reserves & Surplus | 23,853 | 19,729 | 17,415 | 16,897 | 12,890 | 10,273 | 10,284 | 0 | 6,858 | 5,597 |
Zydus Life Science Income Statement Screener - Profit & Revenue Analysis
Screen Zydus Life Science income statement and profit fundamentals.
Analyze ZYDUSLIFE quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Zydus Life Science share price evaluation.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6,892 | 6,147 | 6,622 | 6,371 | 5,181 | 5,182 | 6,110 | 5,526 | 4,403 | 4,313 | 5,089 | 4,890 | 4,199 | 3,993 | 3,989 |
| Expenses | 5,133 | 4,142 | 4,485 | 4,622 | 3,882 | 3,776 | 4,124 | 3,903 | 3,403 | 3,224 | 3,650 | 4,359 | 3,301 | 3,319 | 3,251 |
| EBITDA | 1,759 | 2,005 | 2,137 | 1,749 | 1,299 | 1,407 | 1,986 | 1,623 | 1,000 | 1,089 | 1,439 | 532 | 898 | 673 | 738 |
| Operating Profit % | 24.00% | 31.00% | 31.00% | 27.00% | 24.00% | 26.00% | 32.00% | 27.00% | 22.00% | 24.00% | 28.00% | 10.00% | 21.00% | 16.00% | 17.00% |
| Depreciation | 360 | 302 | 238 | 238 | 229 | 234 | 215 | 205 | 195 | 184 | 180 | 179 | 182 | 182 | 181 |
| Interest | 130 | 101 | 85 | 77 | 32 | 25 | 32 | 35 | 20 | 9 | 18 | 28 | 33 | 35 | 34 |
| Profit Before Tax | 1,353 | 1,687 | 1,921 | 1,672 | 1,184 | 1,271 | 1,900 | 1,550 | 947 | 1,006 | 1,328 | 484 | 781 | 648 | 673 |
| Tax | 331 | 449 | 400 | 428 | 158 | 351 | 417 | 304 | 157 | 203 | 195 | 125 | 149 | 122 | 96 |
| Net Profit | 1,023 | 1,239 | 1,521 | 1,244 | 1,026 | 920 | 1,483 | 1,246 | 790 | 803 | 1,134 | 358 | 631 | 526 | 576 |
| EPS | 10.36 | 12.51 | 14.58 | 11.64 | 10.17 | 9.06 | 14.11 | 11.69 | 7.80 | 7.91 | 10.74 | 2.93 | 6.15 | 5.15 | 5.06 |
Zydus Life Science Cash Flow Screener - Liquidity Fundamentals
Screen ZYDUSLIFE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 6,777 | 3,228 | 2,689 | 2,104 | 3,293 | 2,505 | 1,282 | 919 | 1,312 | 1,894 |
| Investing Activities | -8,377 | -1,492 | 1,178 | 1,137 | -835 | -1,012 | -3,977 | -974 | -2,872 | -860 |
| Financing Activities | 2,014 | -1,810 | -4,400 | -868 | -2,549 | -1,094 | 1,885 | 52 | 2,316 | -935 |
| Net Cash Flow | 414 | -75 | -534 | 2,373 | -91 | 399 | -811 | -3 | 756 | 99 |
Zydus Life Science Shareholding Pattern Screener
See Zydus Life Science shareholding pattern with promoter, FII, and DII holdings.
Check Zydus Life Science promoter holding and ownership changes for ZYDUSLIFE on TickJournal.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 75.00% | 74.99% | 74.99% | 74.99% | 74.98% | 74.98% | 74.98% | 74.98% |
| FII Holding | 7.06% | 7.34% | 7.13% | 7.32% | 7.53% | 7.52% | 5.59% | 5.72% |
| DII Holding | 11.09% | 10.86% | 11.13% | 11.01% | 10.65% | 10.65% | 12.64% | 12.63% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 5.54% | 5.49% | 5.46% | 5.41% | 5.47% | 5.48% | 5.37% | 5.29% |
| Other Holding | 1.31% | 1.32% | 1.28% | 1.28% | 1.36% | 1.37% | 1.43% | 1.38% |
| Shareholder Count | 403,266 | 396,105 | 386,127 | 371,619 | 365,356 | 370,863 | 336,309 | 294,324 |
Zydus Life Science Share Dividend Screener - Share Yield Analysis
Check Zydus Life Science dividend history with payout and yield data.
View Zydus Life Science dividend details including ex-dates and amounts for ZYDUSLIFE stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹11.00 | 1.22% |
| 2024-March | ₹3.00 | 0.34% |
| 2023-March | ₹6.00 | 0.60% |
| 2022-March | ₹2.50 | 0.51% |
| 2021-March | ₹3.50 | 1.00% |
| 2020-March | ₹3.50 | 0.79% |
| 2019-March | ₹3.50 | 1.31% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹3.20 | 0.85% |
Zydus Life Science Stock Index Membership
See which indices include Zydus Life Science stock.
Check ZYDUSLIFE index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Zydus Life Science Market Events Screener - Corporate Actions
Get Zydus Life Science corporate actions including splits, bonuses, and buybacks.
Check Zydus Life Science stock events that may affect ZYDUSLIFE share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-02-09 | 2026-02-09 | Quarterly Result Announcement | NA | 0.67% |
| 2025-11-06 | 2025-11-06 | Quarterly Result Announcement | NA | -2.96% |
| 2025-08-12 | 2025-08-12 | Annual General Meeting | NA | 4.84% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | -1.47% |
| 2025-07-25 | 2025-07-25 | Dividend | ₹ 11.00 /share | 7.57% |
| 2025-05-20 | 2025-05-20 | Quarterly Result Announcement | NA | 4.31% |
| 2025-02-05 | 2025-02-05 | Quarterly Result Announcement | NA | -2.16% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | -3.36% |
| 2024-08-09 | 2024-08-09 | Annual General Meeting | NA | 26.80% |
| 2024-07-26 | 2024-07-26 | Dividend | ₹ 3.00 /share | 19.50% |
| 2024-02-23 | 2024-02-29 | Buyback | 1005 | -2.20% |
| 2023-07-28 | 2023-07-28 | Dividend | ₹ 6.00 /share | 25.19% |
| 2022-07-28 | 2022-07-29 | Dividend | ₹ 2.50 /share | 3.20% |
| 2021-07-28 | 2021-07-30 | Dividend | ₹ 3.50 /share | -8.95% |
Zydus Life Science Competitors Screener - Peer Comparison
Screen ZYDUSLIFE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 408,007 | 37.20 | 54,729 | 9.71% | 10,980 | 53.25 |
| Divis Laboratories | 163,250 | 66.07 | 9,712 | 18.67% | 2,191 | 48.15 |
| Torrent Pharmaceuticals | 144,229 | 64.43 | 11,539 | 6.99% | 1,911 | 70.35 |
| Cipla | 109,566 | 23.71 | 28,410 | 7.12% | 5,291 | 45.95 |
| Dr Reddys Laboratories | 105,948 | 19.16 | 33,741 | 16.73% | 5,725 | 58.53 |
| Lupin | 101,478 | 21.52 | 22,910 | 13.74% | 3,306 | 60.82 |
| Zydus Life Science | 91,613 | 18.12 | 23,511 | 18.55% | 4,615 | 52.96 |
| Mankind Pharma | 86,000 | 47.17 | 12,744 | 20.90% | 2,007 | 45.43 |
| Aurobindo Pharma | 68,802 | 19.14 | 32,346 | 9.43% | 3,484 | 51.95 |
| Alkem Laboratories | 65,528 | 26.80 | 13,458 | 3.70% | 2,216 | 40.44 |
Zydus Life Science Company Announcements - News Screener
Screen ZYDUSLIFE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-02-21 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2026-02-20 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-02-18 | Update On Litigation | View |
| 2026-02-16 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2026-02-16 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-02-15 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-02-15 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2026-02-15 | Board Comments On Penalties Levied By BSE And NSE | View |
| 2026-02-15 | Unaudited Financial Results For The Quarter And Nine Months Ended On December 31 2025 | View |
| 2026-02-15 | Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended On December 31 2025 | View |
| 2026-02-12 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-02-04 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-02-04 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2026-01-31 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2026-01-30 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2026-01-27 | Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter / Nine Months Ended On December 31 2025. | View |
| 2026-01-23 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-01-22 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-01-20 | Revision In ESG Rating | View |
| 2026-01-17 | Update | View |